CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Position in TNXP — Tonix Pharmaceuticals Holding Corp.

CIK 884546 SAN FRANCISCO, CA

Position in TNXP

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$671,341

+$261,729 QoQ

Shares Held

52,613

+76.6% QoQ

Ownership

0.307%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#28

of 103 holders

Holding Since

Sep 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,402,603,842 across 299 Biotechnology names. TNXP ranks #246 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,041,282	$1,013,966,007
2	REGN	Regeneron Pharmaceuticals, Inc.	846,306	$527,705,642
3	RVMD	Revolution Medicines, Inc.	1,917,025	$359,020,441
4	MRNA	Moderna, Inc.	4,838,884	$338,867,045
5	ALNY	Alnylam Pharmaceuticals, Inc.	755,377	$227,391,137
6	INCY	Incyte Corp	1,692,439	$191,854,884
7	RPRX	Royalty Pharma plc	3,083,528	$172,893,414
8	CYTK	Cytokinetics Inc	1,565,781	$133,388,883

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$671,341	52,613	+76.6%	Shares	Sole	2026-08-14
2026-03-31	$409,612	29,790	-10.8%	Shares	Sole	2026-05-15
2025-12-31	$521,770	33,404	+24.7%	Shares	Sole	2026-02-13
2025-09-30	$647,222	26,789	+23.3%	Shares	Sole	2025-11-10
2025-06-30	$781,917	21,732	-98.3%	Shares	Sole	2025-08-12
2022-03-31	$287,231	1,248,831	+14.8%	Shares	Sole	2022-05-13
2021-12-31	$391,583	1,087,732	+23.4%	Shares	Sole	2022-02-11
2021-09-30	$529,040	881,734	+7.7%	Shares	Sole	2021-11-16
2021-06-30	$908,944	818,869	+548.5%	Shares	Sole	2021-08-16
2021-03-31	$161,628	126,272	+38.6%	Shares	Sole	2021-05-17
2020-12-31	$61,945	91,097	0.0%	Shares	Sole	2021-02-16
2020-09-30	$76,521	91,097	—	Shares	Sole	2020-11-13
No filing history on record for this holder in this stock.